• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Communication Services·4390.T
Share

IPS, Inc. Stocks

¥ 3295Last Updated 28.10.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

¥ 267.70M

¥ 3295
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Founded in Tokyo, Japan, in 1991, IPS, Inc. delivers a comprehensive suite of information technology and telecommunication services across both Japan and the Philippines. Its primary offerings include internet access, robust data center solutions, and domestic telecommunications, which spans toll-free services, support for Mobile Virtual Network Operators (MVNOs), trunk infrastructure, and other value-added provisions. The company also oversees network services for both local and international telecom providers and supplies international communication lines. Additionally, IPS, Inc. provides the CloudSigma cloud computing platform, AmeyoJ contact center management software, and various business process outsourcing (BPO) services. Beyond its tech ventures, the firm operates medical clinics specializing in procedures like laser-eye surgery, aesthetic dermatology, cosmetic dentistry, and cataract removal, alongside managing an online pharmacy.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.10.2026 20:43

Shares of the struggling Jeep manufacturer soared. What convinced investors?

28.10.2026 20:32

Shares of the Wendy's burger chain soared 15%: a billionaire investor wants to buy it out

28.10.2026 19:03

Betting on the Cloud: What Wall Street Expects from Microsoft's Earnings Report

28.10.2026 17:49

BofA reiterates 'buy' on game developer Take-Two ahead of GTA VI launch

28.10.2026 17:01

AI data firm Innodata sinks on mass layoffs amid reduced work for major client

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026